54 / 210
XXXII Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia
54
14. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin
T. High rate of unprovoked recurrent venous thrombosis is associa-
ted with high thrombin-generating potential in a prospective cohort
study. J Thromb Haemost 2008;6(10):1720-5.
15. Donadini MP, Ageno W, Antonucci E, Cosmi B, Kovacs MJ, Le Gal
G, et al. Prognostic significance of residual venous obstruction in
patients with treated unprovoked deep vein thrombosis: a patient-
level meta-analysis. Thromb Haemost 2014; 111(1):172-9.
16. 16. Van der Hulle T, den Exter PL, van den Hoven P, van der Hoeven
JJ, van der Meer FJ, Eikenboom J, et al. Cohort Study on the Mana-
gement of Cancer-Associated Venous Thromboembolism Aimed at
the Safety of Stopping Anticoagulant Therapy in Patients Cured of
Cancer. Chest 2016;149(5):1245-51.
17. Louzada ML, Carrier M, Lazo-Langner A, Dao V, Kovacs MJ,
Ramsay TO, et al. Development of a clinical prediction rule for
risk stratification of recurrent venous thromboembolism in patients
with cancer-associated venous thromboembolism. Circulation
2012;126(4):448-54.
18. Von Känel R, Margani A, Stauber S, Meyer FA, Demarmels Bia-
siutti F, Vökt F, et al. Depressive symptoms as a novel risk factor
for recurrent venous thromboembolism: a longitudinal observational
study in patients referred for thrombophilia investigation. PLoS One
2015;10(5):e0125858.
19. Muriel A, Jiménez D, Aujesky D, Bertoletti L, Decousus H, Laporte
S, et al. Survival effects of inferior vena cava filter in patients with
acute symptomatic venous thromboembolism and a significant ble-
eding risk. J Am Coll Cardiol 2014;63(16):1675-83.
20. White RH, Brunson A, Romano PS, Li Z, Wun T. Outcomes After
Vena Cava Filter Use in Non-Cancer Patients with Acute Venous
Thromboembolism: A Population-Based Study. Circulation 2016
(en prensa).
21. Tagalakis V, Eberg M, Kahn S, Azoulay L. Use of statins and reduced
risk of recurrence of VTE in an older population. A population-based
cohort study. Thromb Haemost 2016 (en prensa).
22. Smith NL, Harrington LB, Blondon M, Wiggins KL, Floyd JS,
Sitlani CM, et al. The Association of Statin Therapy with the Risk
of Recurrent Venous Thrombosis. J Thromb Haemost 2016 (en
prensa).
23. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le
Gal G, et al. Identifying unprovoked thromboembolism patients at
low risk for recurrence who can discontinue anticoagulant therapy.
CMAJ 2008;179(5):417-26.
24. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment
of recurrence in patients with unprovoked deep vein thrombosis
or pulmonary embolism: the Vienna prediction model. Circulation
2010;121(14):1630-6.
25. Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichin-
ger S, et al. Predicting disease recurrence in patients with previous
unprovoked venous thromboembolism: a proposed prediction score
(DASH). J Thromb Haemost 2012;10(6): 1019-25.
26. Franco Moreno AI, García Navarro MJ, Ortiz Sánchez J, Martín
Díaz RM, Madroñal Cerezo E, de Ancos Aracil CL, et al. A risk sco-
re for prediction of recurrence in patients with unprovoked venous
thromboembolism (DAMOVES). Eur J Intern Med 2016;29:59-64.